These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


792 related items for PubMed ID: 6304810

  • 1. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
    Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS.
    Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
    [Abstract] [Full Text] [Related]

  • 2. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, Kitabatake A, Kamada T, Kimura K, Kozuka T.
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [Abstract] [Full Text] [Related]

  • 6. Abnormal scintigraphic evolution in AA hepatic amyloidosis.
    Lomeña F, Roselló R, Pons F, Grau M, García A, Catafau A, Setoain J.
    Clin Nucl Med; 1988 Mar; 13(3):194-6. PubMed ID: 2838214
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S, Olofsson BO.
    Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
    [Abstract] [Full Text] [Related]

  • 12. Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.
    Bokhari S, Morgenstern R, Weinberg R, Kinkhabwala M, Panagiotou D, Castano A, DeLuca A, Kontak A, Jin Z, Maurer MS.
    J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616
    [Abstract] [Full Text] [Related]

  • 13. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R, Neumann R, Goldsmith SJ.
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [Abstract] [Full Text] [Related]

  • 14. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
    Chen W, Dilsizian V.
    Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T, Horinouchi H, Hashimoto K, Ichiji T, Yoshioka K, Hashimoto J, Ikari Y.
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis.
    Leinonen H, Tötterman KJ, Korppi-Tommola T, Korhola O.
    Am J Cardiol; 1984 Jan 15; 53(2):380-1. PubMed ID: 6320621
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.